From Barrier Disruption to Precision Skin Interface Engineering: Next‐Generation Transdermal Drug Delivery
The Chemical Record · 09.09.2026
DOI: 10.1002/tcr.70249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Chemical Record, online erschienen am 09.09.2026. Verfasst von Cong-Zheng Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Functional and Biomedical Nanomaterials, College of Materials Science and Engineering, Qingdao University of Science and Technology (QUST), Qi…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 203 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Natural Science Foundation of Qingdao Municipality.
Abstract (Originalsprache)
Transdermal drug delivery (TDD) is reemerging as a clinically attractive route for noninvasive therapy, driven by the growing demand for alternatives to repeated injection and by the rapid development of materials capable of regulating transport across the skin. By avoiding gastrointestinal degradation and hepatic first‐pass metabolism, TDD can provide prolonged drug exposure, reduce peak‐to‐trough fluctuations in plasma concentration, and improve adherence in long‐term treatment. Its broader implementation, however, is still constrained by the exceptional barrier function of the stratum corneum, which severely limits the passive transport of hydrophilic molecules, charged species, and macromolecular therapeutics. In this review, we critically discuss the structural basis of the skin barrier and summarize the evolution of TDD strategies from conventional chemical permeation enhancement and device‐assisted physical disruption to nanocarrier‐mediated, biomimetic, and intelligent bio‐delivery systems. Particular emphasis is placed on the mechanistic logic that connects carrier composition, interfacial interactions, skin microenvironment remodeling, and therapeutic performance. Representative examples are analyzed to highlight both opportunities and translational bottlenecks. Finally, we outline future directions in multimodal delivery, pathology‐adapted design, standardized evaluation, and scalable manufacturing, which will be essential for transforming TDD from a permeability enhancement technology into a precision‐regulated therapeutic platform.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lab of Functional and Biomedical Nanomaterials, College of Materials Science and Engineering, Qingdao University of Science and Technology (QUST), Qingdao, P. R. China.
ORCID-Profile: Sheng-Lin Qiao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Natural Science Foundation of Qingdao Municipality
- Startup Funds from Qingdao University of Science and Technology
Zitieren
APA
Zhou, C. Z., Lin, X. Y., Yu, S. S., & Qiao, S. L. (2026). From Barrier Disruption to Precision Skin Interface Engineering: Next‐Generation Transdermal Drug Delivery. The Chemical Record. https://doi.org/10.1002/tcr.70249
Vancouver
Zhou CZ, Lin XY, Yu SS, Qiao SL. From Barrier Disruption to Precision Skin Interface Engineering: Next‐Generation Transdermal Drug Delivery. The Chemical Record. 2026. doi:10.1002/tcr.70249
BibTeX
@article{Zhou2026,
author = {Zhou, Cong-Zheng and Lin, Xin-Yu and Yu, Shou-Shan and Qiao, Sheng-Lin},
title = {From Barrier Disruption to Precision Skin Interface Engineering: Next‐Generation Transdermal Drug Delivery},
journal = {The Chemical Record},
year = {2026},
doi = {10.1002/tcr.70249}
}
EUVIMED